Rallybio Corp (RLYB): Nasdaq/NYSE listing notice — Rallybio fails Nasdaq bid price compliance; transfer to Capital Market grants extension to Feb 2026

Rallybio Corp

Nasdaq notified Rallybio on Aug 26, 2025 of transfer to Capital Market; stock continues trading as RLYB.
Company failed to regain $1.00 minimum bid price by Aug 25, 2025 deadline; new compliance date is Feb 23, 2026.
If not compliant by Feb 23, 2026, Nasdaq will issue delisting notice; Rallybio may appeal or pursue reverse stock split.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Rallybio Corp received a nasdaq noncompliance notice notice regarding minimum bid price.

Exchange: nasdaq
Notice: noncompliance notice
Deficiency: minimum bid price

Exact text from the filing

February 24, 2025, the Company received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) Listing Qualifications Department notifying the Company that the closing bid price of the Company’s shares of common stock was below the minimum closing bid price of $1.00 per share during the prior 30 consecutive business days (the “Notice”), as required for continued listing on the Nasdaq. Pursuant to Nasdaq’s Listing Rules, the Company had until August 25, 2025 (the “Initial Compliance Date”) to regain compliance with the minimum closing bid price requirement. As of the Initial Complian

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Rallybio Corp filing history →

Source: SEC EDGAR

accession 0001193125-25-192749

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.